BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 37195071)

  • 1. Taurochenodeoxycholic acid inhibits intestinal epithelial cell proliferation and induces apoptosis independent of the farnesoid X receptor.
    Liu Y; Niu K; Wang R; Liang X; Lin C; Wu X; Zhai Z
    Food Funct; 2023 Jun; 14(11):5277-5289. PubMed ID: 37195071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small intestinal taurochenodeoxycholic acid-FXR axis alters local nutrient-sensing glucoregulatory pathways in rats.
    Waise TMZ; Lim YM; Danaei Z; Zhang SY; Lam TKT
    Mol Metab; 2021 Feb; 44():101132. PubMed ID: 33264656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Taurochenodeoxycholic acid inhibits the proliferation and invasion of gastric cancer and induces its apoptosis.
    Zhang D; Zhu Y; Su Y; Yu M; Xu X; Wang C; Zhang S; Xia L
    J Food Biochem; 2022 Mar; 46(3):e13866. PubMed ID: 34278593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FXR in the dorsal vagal complex is sufficient and necessary for upper small intestinal microbiome-mediated changes of TCDCA to alter insulin action in rats.
    Zhang SY; Li RJW; Lim YM; Batchuluun B; Liu H; Waise TMZ; Lam TKT
    Gut; 2021 Sep; 70(9):1675-1683. PubMed ID: 33087489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Taurochenodeoxycholic acid induces NR8383 cells apoptosis via PKC/JNK-dependent pathway.
    Wang X; Zhang Z; He X; Mao W; Zhou L; Li P
    Eur J Pharmacol; 2016 Sep; 786():109-115. PubMed ID: 27268718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyodeoxycholic acid (HDCA) suppresses intestinal epithelial cell proliferation through FXR-PI3K/AKT pathway, accompanied by alteration of bile acids metabolism profiles induced by gut bacteria.
    Song M; Yang Q; Zhang F; Chen L; Su H; Yang X; He H; Liu F; Zheng J; Ling M; Lai X; Zhu X; Wang L; Gao P; Shu G; Jiang Q; Wang S
    FASEB J; 2020 May; 34(5):7103-7117. PubMed ID: 32246800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Taurochenodeoxycholic acid reduces astrocytic neuroinflammation and alleviates experimental autoimmune encephalomyelitis in mice.
    Xu N; Bai Y; Han X; Yuan J; Wang L; He Y; Yang L; Wu H; Shi H; Wu X
    Immunobiology; 2023 May; 228(3):152388. PubMed ID: 37079985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Taurochenodeoxycholic acid induces apoptosis of fibroblast-like synoviocytes.
    Li L; Liu C; Liu M; Shi L; Liu Q; Guan H; Li P
    Eur J Pharmacol; 2013 Apr; 706(1-3):36-40. PubMed ID: 23510744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Src-mediated cross-talk between farnesoid X and epidermal growth factor receptors inhibits human intestinal cell proliferation and tumorigenesis.
    Peng Z; Raufman JP; Xie G
    PLoS One; 2012; 7(10):e48461. PubMed ID: 23119029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aflatoxin B1 Induces Intestinal Barrier Dysfunction by Regulating the FXR-Mediated MLCK Signaling Pathway in Mice and in IPEC-J2 Cells.
    Liu S; Li J; Kang W; Li Y; Ge L; Liu D; Liu Y; Huang K
    J Agric Food Chem; 2023 Jan; 71(1):867-876. PubMed ID: 36579420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Taurochenodeoxycholic Acid Increases cAMP Content via Specially Interacting with Bile Acid Receptor TGR5.
    Qi Y; Shi L; Duan G; Ma Y; Li P
    Molecules; 2021 Nov; 26(23):. PubMed ID: 34885648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential activation of the human farnesoid X receptor depends on the pattern of expressed isoforms and the bile acid pool composition.
    Vaquero J; Monte MJ; Dominguez M; Muntané J; Marin JJ
    Biochem Pharmacol; 2013 Oct; 86(7):926-39. PubMed ID: 23928191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective Effects of Selenium Nanoparticles against Bisphenol A-Induced Toxicity in Porcine Intestinal Epithelial Cells.
    Pan Z; Huang J; Hu T; Zhang Y; Zhang L; Zhang J; Cui D; Li L; Wang J; Wu Q
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Wnt/β-catenin-mediated heat exposure inhibits intestinal epithelial cell proliferation and stem cell expansion through endoplasmic reticulum stress.
    Zhou JY; Huang DG; Zhu M; Gao CQ; Yan HC; Li XG; Wang XQ
    J Cell Physiol; 2020 Jul; 235(7-8):5613-5627. PubMed ID: 31960439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of farnesoid X receptor controls esophageal cancer cell growth in vitro and in nude mouse xenografts.
    Guan B; Li H; Yang Z; Hoque A; Xu X
    Cancer; 2013 Apr; 119(7):1321-9. PubMed ID: 23280144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clostridium Tyrobutyricum Protect Intestinal Barrier Function from LPS-Induced Apoptosis via P38/JNK Signaling Pathway in IPEC-J2 Cells.
    Xiao Z; Liu L; Tao W; Pei X; Wang G; Wang M
    Cell Physiol Biochem; 2018; 46(5):1779-1792. PubMed ID: 29705796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eleutheroside B increase tight junction proteins and anti-inflammatory cytokines expression in intestinal porcine jejunum epithelial cells (IPEC-J2).
    Che D; Zhao B; Fan Y; Han R; Zhang C; Qin G; Adams S; Jiang H
    J Anim Physiol Anim Nutr (Berl); 2019 Jul; 103(4):1174-1184. PubMed ID: 30990939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bile salt supplementation acts via the farnesoid X receptor to alleviate lipopolysaccharide-induced intestinal injury.
    Zahiri HR; Perrone EE; Strauch ED
    Surgery; 2011 Sep; 150(3):480-9. PubMed ID: 21878234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concerted action of berberine in the porcine intestinal epithelial model IPEC-J2: Effects on tight junctions and apoptosis.
    Cornelius V; Droessler L; Boehm E; Amasheh S
    Physiol Rep; 2022 Apr; 10(7):e15237. PubMed ID: 35384371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphatidylinositol 3-kinase-dependent signaling modulates taurochenodeoxycholic acid-induced liver injury and cholestasis in perfused rat livers.
    Rust C; Bauchmuller K; Fickert P; Fuchsbichler A; Beuers U
    Am J Physiol Gastrointest Liver Physiol; 2005 Jul; 289(1):G88-94. PubMed ID: 15746212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.